期刊文献+

大黄消痔栓治疗湿热瘀阻型慢性非细菌性前列腺炎/慢性骨盆疼痛综合征临床研究 被引量:7

Clinical Study on Dahuang Xiaozhi Suppository in Treating Chronic Abacterial Prostatitis/Chronic Pelvic Pain Syndrome of Moist Heat and Blood Stasis Syndrome
下载PDF
导出
摘要 目的观察大黄消痔栓治疗湿热瘀阻型慢性非细菌性前列腺炎/慢性骨盆疼痛综合征(CABP/CPPS)的临床疗效。方法选取CABP/CPPS湿热瘀阻型患者200例,随机分为观察组和对照组各100例。2组均停用抗感染药物和其他制剂,予饮食及生活干预。对照组予前列安栓,观察组予大黄消痔栓,每次1粒,每日1次,纳肛,置入肛门3~4 cm。10 d为1个疗程,疗程间隔2 d,治疗3个疗程。观察2组临床疗效及治疗前后NIH慢性前列腺炎症状指数(NIH-CPSI)评分、前列腺液白细胞计数、卵磷脂小体、尿流率变化。结果观察组总有效率为100%(100/100),对照组为78%(78/100),观察组明显高于对照组(P<0.05)。与治疗前比较,2组前列腺液白细胞计数、NIH-CPSI评分均降低(P<0.01),观察组明显低于对照组(P<0.01);治疗后2组卵磷脂小体++++者均增多(P<0.01),观察组明显多于对照组(P<0.01);2组尿流率均升高(P<0.05),观察组高于对照组(P<0.01)。结论大黄消痔栓治疗湿热瘀阻型CABP/CPPS疗效显著,效果优于前列安栓。 Objective To investigate the clinical efficacy of Dahuang Xiaozhi Suppository in treating chronicabacterial prostatitis/chronic pelvic pain syndrome(CABP/CPPS)of moist heat and blood stasis syndrome.Methods Two hundred patients of CABP/CPPS were randomly divided into control group and observation group,100cases in each group.2groups were disabled anti-infective meidicne and other preparations,and received diet and lifeintervention.The control group received the treatment of Qianliean Suppository,and the observation group receivedthe treatment of Dahuang Xiaozhi Suppository,one capsule each time,once a day,into the anus depth of about3–4cm.Ten days were a treatment course with two day interval between each course of treatment.The treatmentlasted for three courses.The clinical efficacy of the two groups was observed and compared.The indexes includingthe scores of NIH-CPSI,leukocyte count and lecithin corpuscles in prostatic fluid,and urinary flow rate wereevaluated.Results The total effective rate was100%(100/100)in the observation group and78%(78/100)in thecontrol group,and the observation group was much higher than control group(P<0.05).The scores of NIH-CPSI andleukocyte count in both groups were significantly lower after treatment(P<0.01),and those in observation group were significantly lower than those in control group(P<0.01).The cases with lecithin corpuscles++++in both groups weresignificantly more after treatment(P<0.01),and those in observation group were significantly more than those incontrol group(P<0.01).The peak flow rate and mean flow rate in both groups were higher after treatment(P<0.01),and it was higher in observation group(P<0.01).Conclusion The efficacy of Dahuang Xiaozhi Suppository intreating CABP/CPPS of moist heat and blood stasis syndrome is remarkable,and it is better than QianlieanSuppository.
作者 王新平 易剑锋 田跃军 邢喜平 孟瑞霞 张骕 付生军 杨立 WANG Xin-ping;YI Jian-feng;TIAN Yue-jun;XING Xi-ping;MENG Rui-xia;ZHANG Su;FU Sheng-jun;YANG Li(Institute of Urology of Lanzhou University, Gansu Nephron-Urological Clinical Center, Key Laboratory of Diseases of Urological System in Gansu Province, Lanzhou University Second Hospital, Lanzhou 730030, China;Affiliated Hospital of Gansu University of Chinese Medicine, Lanzhou 730000, China;Clinical School, Gansu University of Chinese Medicine, Lanzhou 730000, China)
出处 《中国中医药信息杂志》 CAS CSCD 2017年第3期22-25,共4页 Chinese Journal of Information on Traditional Chinese Medicine
基金 国家自然科学基金(81060304) 甘肃省中医药管理局科研课题(GEK-2015-63)
关键词 大黄消痔栓 慢性非细菌性前列腺炎/慢性骨盆疼痛综合征 湿热瘀阻证 临床研究 Dahuang Xiaozhi Suppository chronic abacterial prostatitis/chronic pelvic pain syndrome moist heat and blood stasis syndrome clinical study
  • 相关文献

参考文献4

二级参考文献30

  • 1叶锦,陈锦,余军,杨兵,张玮.α_1-受体阻滞剂对慢性非细菌性前列腺炎治疗的效果[J].第三军医大学学报,2004,26(12):1126-1126. 被引量:4
  • 2沈柏华,金晓东,蔡松良,陈军,陈戈明,赵伟平,孙欣.α1受体阻滞剂联合抗生素治疗慢性前列腺炎疗效及机制[J].中华男科学杂志,2004,10(7):518-520. 被引量:57
  • 3崔彦如.少腹逐瘀汤加减治疗血瘀型慢性前列腺炎60例[J].四川中医,2004,22(10):45-46. 被引量:5
  • 4.中药新药临床研究指导原则:第三辑[S].[S].中华人民共和国卫生部,1997.145-146.
  • 5Litwin M S, Mcnaughton M, Fowler FJ, et al. The National Institutes of Health chronic prostatis symptom index:devdopment and validation of new outcome measure. J Urol 1999;162:369
  • 6Nuckel JC, Nyberg LM, Hennenfent MI. Research guidlines for chronic prostatis:consensus report from the first national institutes of health international prostatitis collaborative network Urology 1999; 54: 229
  • 7Krieger J N, Nyberg L J,Nickel J C. NIH consensusdefinition and classification of prostatitis [ J ]. JAMA,1999 ,282(3) :236.
  • 8Schaeffer A J, Knauss J S, Landis J R, et al.Leukocyte and bacterial counts do not correlate withseverity of symptoms in men with chronic prostatitis : TheNational Institutes of Health Chronic Prostatitis CohortStudy [J]. J Urol, 2002,168(3):1048.
  • 9Litwin M S,Me Naughton-Collins M,Fowler F J Jr, etal. The national institutes of health chronic prostatitfissymptom index : development and validation of a newoutcome measure. Chronic Prostatitis CollaborativeResearch Network [J]. J Urol, 1999 , 162(2):369.
  • 10Nickel J C, Nyberg L M, Hennennfent M. Researchguidelines for chronic prostatitis : consensus report fromthe first National Institutes of Health-internationalProstatitis Collaborative Network [ J ]. Urology, 1999,54 (2) :229.

共引文献211

同被引文献94

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部